ResearchMoz presents professional and in-depth study of "Fungal Foot Infections Drug Development Pipeline Review, 2018".
This report provides an overview of the fungal foot infection pipeline landscape. It provides comprehensive information on the therapeutics under development for onychomycosis (Tinea unguium) and athletes foot (Tinea pedis), and key players active within these indications.
Both of these indications are fungal infections primarily affecting the feet. Onychomycosis affects the nails, whereas athletes foot affects the skin under the feet and between the toes. Common symptoms include discomfort, itchiness, and - in the case of onychomycosis - discoloured and disfigured nails. Combined, these infections affect around 25% of the adult population.
Get Free PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1701730
There is considerable overlap in both the development of pipeline products and existing marketed products between the two indications, which reflects similarities in the underlying pathophysiology. There are a total of 25 products in development for both indications, by 24 companies.
Scope
- Which companies are the most active within each pipeline?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared with pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in this disease area?
Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration
Table of Contents
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Fungal Foot Infections Report Coverage 7
2.2 Onychomycosis (Tinea Unguium) - Overview 7
2.3 Tinea pedis (Athlete Foot) - Overview 7
3 Therapeutics Development 8
3.1 Onychomycosis (Tinea Unguium) 8
3.2 Tinea pedis (Athlete Foot) 12
4 Therapeutics Assessment 15
4.1 Onychomycosis (Tinea Unguium) 15
4.2 Tinea pedis (Athlete Foot) 21
Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1701730
5 Companies Involved in Therapeutics Development 26
5.1 Onychomycosis (Tinea Unguium) 26
5.2 Tinea pedis (Athlete Foot) 32
6 Dormant Projects 36
6.1 Onychomycosis (Tinea Unguium) 36
6.2 Tinea pedis (Athlete Foot) 38
7 Discontinued Products 39
7.1 Onychomycosis (Tinea Unguium) 39
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/
This report provides an overview of the fungal foot infection pipeline landscape. It provides comprehensive information on the therapeutics under development for onychomycosis (Tinea unguium) and athletes foot (Tinea pedis), and key players active within these indications.
Both of these indications are fungal infections primarily affecting the feet. Onychomycosis affects the nails, whereas athletes foot affects the skin under the feet and between the toes. Common symptoms include discomfort, itchiness, and - in the case of onychomycosis - discoloured and disfigured nails. Combined, these infections affect around 25% of the adult population.
Get Free PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1701730
There is considerable overlap in both the development of pipeline products and existing marketed products between the two indications, which reflects similarities in the underlying pathophysiology. There are a total of 25 products in development for both indications, by 24 companies.
Scope
- Which companies are the most active within each pipeline?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared with pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in this disease area?
Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration
Table of Contents
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Fungal Foot Infections Report Coverage 7
2.2 Onychomycosis (Tinea Unguium) - Overview 7
2.3 Tinea pedis (Athlete Foot) - Overview 7
3 Therapeutics Development 8
3.1 Onychomycosis (Tinea Unguium) 8
3.2 Tinea pedis (Athlete Foot) 12
4 Therapeutics Assessment 15
4.1 Onychomycosis (Tinea Unguium) 15
4.2 Tinea pedis (Athlete Foot) 21
Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1701730
5 Companies Involved in Therapeutics Development 26
5.1 Onychomycosis (Tinea Unguium) 26
5.2 Tinea pedis (Athlete Foot) 32
6 Dormant Projects 36
6.1 Onychomycosis (Tinea Unguium) 36
6.2 Tinea pedis (Athlete Foot) 38
7 Discontinued Products 39
7.1 Onychomycosis (Tinea Unguium) 39
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/
No comments:
Post a Comment